With UK researchers on the forefront of fighting the opioid crisis, their message to members of the U.S. House of Representatives and Senate emphasized the need for continued federal funding of research addressing drug addiction and abuse.
Stoops hopes his research will contribute to the evolving knowledge of treatment for cocaine use disorder (CUD), a substance use disorder that currently has no well-established treatment methods.
UK's Building Interdisciplinary Research Careers in Women's Health program has not only supported faculty and researchers in their work, but also jump-started careers, aided in publications and helped forge partnerships and mentorships across disciplines.
The University of Kentucky Markey Cancer Center is one of 22 cancer centers nationwide to receive funding to build and implement tobacco cessation treatment programs via the National Cancer Institute's Cancer Center Cessation Initiative (CCCI).
The Hillman Innovations in Care Program grant will be used to expand access to the PATHways program in communities who may not have the resources available to provide this type of multidisciplinary care to mothers with perinatal opioid use disorder.
The UK College of Public Health and the Commonwealth of Kentucky will receive funding over the next three years from the Bureau of Justice Assistance, U.S. DOJ, to implement, "Data-driven Response to Prescription Drug Misuse in Kentucky."
This fall, Nancy Schoenberg and her team of community and university researchers in the UK College of Medicine and the UK College of Public Health were awarded a new five-year, $3.1 million grant from the National Institutes of Diabetes and Digestive and Kidney Diseases to continue the Faith Moves Mountains initiative.
The Center for Clinical and Translational Science, in conjunction the Western States Consortium, is currently accepting applications for innovative, translational research projects that involve two or more institutions within the Consortium.
The National Institutes of Health has awarded a five year, $2.88 million grant to a researcher at the Sanders-Brown Center on Aging to study a drug's potential to prevent Alzheimer's disease.
